Clinical Trials Directory

Trials / Completed

CompletedNCT05502510

Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application

Status
Completed
Phase
Study type
Observational
Enrollment
12,344 (actual)
Sponsor
Naima Health LLC · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

One in ten births will occur prior to 37 weeks of gestation leading to serious complications such as problems with lung, heart and brain function and an increased risk of infant mortality. Solutions exist to treat risk factors related to preterm birth but these solutions require timely identification of the risks which is often not possible within regular prenatal care. This study will evaluate MyHealthyPregnancy, an application that monitors for common risks associated with preterm birth and recommends solutions to the expectant mother and care team.

Detailed description

MyHealthyPregnancy (MHP) is an application that was developed using behavioral decision science principles. This study seeks to evaluate the effectiveness and efficacy of the application. MyHealthyPregnancy was offered to expectant mothers at the University of Pittsburgh Medical Center in conjunction with usual prenatal care. The primary objective is to compare the reduction in gestational age at birth between MHP and usual care cohorts. Secondary objectives include comparing births occurring prior to 37 weeks of gestation, depression rates, anxiety rates, referrals to behavioral health, referrals to social workers, preeclampsia rates, gestational weight gain, number of prenatal appointments attended, and percent of required prenatal appointments attended between the MHP and usual care cohorts.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMyHealthyPregnancyMyHealthyPregnancy is a mobile application prescribed to expectant mothers in conjunction with normal prenatal care. The application uses behavioral decision science principles to identify risks of preterm birth and alert the mother and care team of these risks.

Timeline

Start date
2019-09-23
Primary completion
2022-02-28
Completion
2022-02-28
First posted
2022-08-16
Last updated
2022-08-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05502510. Inclusion in this directory is not an endorsement.